Voyager Therapeutics, Inc. (NASDAQ: VYGR) Stock Information | RedChip

Voyager Therapeutics, Inc. (NASDAQ: VYGR)


$6.7100
-0.1300 ( -1.90% ) 45.4K

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Market Data


Open


$6.7100

Previous close


$6.8400

Volume


45.4K

Market cap


$373.01M

Day range


$6.6510 - $7.0170

52 week range


$5.7100 - $11.7200

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
8-k 8K-related 13 Jun 06, 2024
8-k 8K-related 13 May 16, 2024
8-k 8K-related 15 May 13, 2024

Latest News